Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Angiomyolipoma differential diagnosis

Introduction

Overview

Overview

Angiomyolipoma must be differentiated from retroperitoneal liposarcoma, adrenal myelolipoma, and renal cell carcinoma.[1][2]

Differentiating Angiomyolipoma from other Diseases

Differentiating Angiomyolipoma from other Diseases

Angiomyolipoma must be differentiated from the following:[1][3][4][5][6]

Differential diagnosis Characteristic features of the differential diagnosis
Retroperitoneal liposarcoma
Renal cell carcinoma
Oncocytoma
  • May contain fat
Wilm’s tumor
  • May contain fat
Retroperitoneal sarcoma
Renal cell carcinoma
  • Sarcomatoid differentiation
Renal leiomyoma
Perirenal fat entrapment
  • Renal junctional parenchymal defect
Adrenal myelolipoma
  • Fat in renal parenchyma
References

References

  1. ↑ 1.0 1.1 Patil, PA.; McKenney, JK.; Trpkov, K.; Hes, O.; Montironi, R.; Scarpelli, M.; Nesi, G.; Aron, M.; Sangoi, AR. (2014). “Renal Leiomyoma: A Contemporary Multi-institution Study of an Infrequent and Frequently Misclassified Neoplasm”. Am J Surg Pathol. doi:10.1097/PAS.0000000000000354. PMID 25517956. Unknown parameter |month= ignored (help)
  2. ↑ Renal angiomyolipoma differential diagnosis. Dr Matt A. Morgan and Dr Behrang Amini et al. Radiopaedia 2015. http://radiopaedia.org/articles/renal-angiomyolipoma
  3. ↑ N. Azumi, J. Curtis, R. L. Kempson & M. R. Hendrickson (1987). “Atypical and malignant neoplasms showing lipomatous differentiation. A study of 111 cases”. The American journal of surgical pathology. 11 (3): 161–183. PMID 3826477. Unknown parameter |month= ignored (help)
  4. ↑ Emily Z. Keung, Jason L. Hornick, Monica M. Bertagnolli, Elizabeth H. Baldini & Chandrajit P. Raut (2014). “Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery”. Journal of the American College of Surgeons. 218 (2): 206–217. doi:10.1016/j.jamcollsurg.2013.10.009. PMID 24315890. Unknown parameter |month= ignored (help)
  5. ↑ Khin Thway, Robin L. Jones, Jonathan Noujaim, Shane Zaidi, Aisha B. Miah & Cyril Fisher (2016). “Dedifferentiated Liposarcoma: Updates on Morphology, Genetics, and Therapeutic Strategies”. Advances in anatomic pathology. 23 (1): 30–40. doi:10.1097/PAP.0000000000000101. PMID 26645460. Unknown parameter |month= ignored (help)
  6. ↑ Cohen AJ, Li FP, Berg S, Marchetto DJ, Tsai S, Jacobs SC; et al. (1979). “Hereditary renal-cell carcinoma associated with a chromosomal translocation”. N Engl J Med. 301 (11): 592–5. doi:10.1056/NEJM197909133011107. PMID 470981.
  7. ↑ Kate Lynn J. Bill, Lucia Casadei, Bethany C. Prudner, Hans Iwenofu, Anne M. Strohecker & Raphael E. Pollock (2016). “Liposarcoma: molecular targets and therapeutic implications”. Cellular and molecular life sciences : CMLS. 73 (19): 3711–3718. doi:10.1007/s00018-016-2266-2. PMID 27173057. Unknown parameter |month= ignored (help)
  8. ↑ Cohen HT, McGovern FJ (2005). “Renal-cell carcinoma”. N Engl J Med. 353 (23): 2477–90. doi:10.1056/NEJMra043172. PMID 16339096.

Template:WikiDoc Sources

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2],Rekha, M.D.